Prevalence and risk factors of trastuzumab induced cardiotoxicity in Tunisian HER2-positive breast cancer patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners(2023)

引用 0|浏览1
暂无评分
摘要
Our study highlighted that obesity is associated with a high risk of cardiotoxicity in women treated with Trastuzumab. Therefore, close monitoring of cardiac function is recommended especially for obese women during Trastuzumab administering.
更多
查看译文
关键词
Trastuzumab,cardiotoxicity,prevalence,risk factor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要